Related Experiment Video
Updated: Jul 9, 2026
09:02
A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Inoprotection: the perioperative role of levosimendan.
P E Soeding1, C F Royse, C E Wright
1Cardiovascular Therapeutics Unit, Department of Pharmacology, University of Melbourne, Melbourne, Victoria, Australia.
Anaesthesia and Intensive Care
|December 19, 2007
Summary
Levosimendan enhances heart contractility by increasing calcium sensitivity without raising oxygen demand. This novel inotrope also activates potassium channels, offering cardioprotection against ischemia and improving outcomes in heart failure patients.
Area of Science:
- Pharmacology
- Cardiology
- Cellular Physiology
Background:
- Levosimendan is a novel inotropic agent with cardioprotective properties.
- It enhances myocardial contractility by sensitizing myofilaments to calcium.
- Levosimendan activates adenosine triphosphate-dependent potassium channels.
Purpose of the Study:
- To review the pharmacology of levosimendan.
- To discuss clinical experience with levosimendan.
- To explore the potential of levosimendan as a cardioprotective agent.
Main Methods:
- Review of existing literature on levosimendan's pharmacology.
- Analysis of clinical trial data in heart failure and ischemia.
- Examination of mechanisms of action, including potassium channel activation.
Main Results:
- Levosimendan increases myocardial contractility without increasing oxygen consumption.
- Activation of adenosine triphosphate-dependent potassium channels offers protection against ischemia-reperfusion injury.
- Clinical trials demonstrate improved hemodynamic performance and potential survival benefits in heart failure patients.
Conclusions:
- Levosimendan is a promising cardioprotective inotrope with a unique mechanism of action.
- Its ability to activate potassium channels suggests protective effects beyond the myocardium.
- Further investigation into levosimendan's role in surgery and other conditions is warranted.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:22Aneurysm IV: Nursing Management
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...